343 related articles for article (PubMed ID: 17889537)
21. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Tabata M; Shimizu M; Araake M; Ogawa H
Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
[TBL] [Abstract][Full Text] [Related]
22. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
[TBL] [Abstract][Full Text] [Related]
23. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
[TBL] [Abstract][Full Text] [Related]
24. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
25. Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Kobayashi T; Gomi K; Abe T; Nukiwa T; Watanabe A
FEMS Microbiol Lett; 2000 Sep; 190(2):299-303. PubMed ID: 11034295
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
[TBL] [Abstract][Full Text] [Related]
27. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
[TBL] [Abstract][Full Text] [Related]
28. Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Watanabe A
Tohoku J Exp Med; 1998 Sep; 186(1):67-70. PubMed ID: 9915109
[TBL] [Abstract][Full Text] [Related]
29. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.
Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1995 Jun; 35(6):865-8. PubMed ID: 7559197
[TBL] [Abstract][Full Text] [Related]
30. [Arbekacin resistant gene, aacA/aphD, in Staphylococcus aureus is lost during in vitro passage].
Chen G; Fukuchi K; Wakuta R; Kubo S; Yasuhara T; Takagi Y; Gomi K
Rinsho Byori; 2002 Jan; 50(1):79-84. PubMed ID: 11871141
[TBL] [Abstract][Full Text] [Related]
31. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Oct; 45(10):1312-8. PubMed ID: 1479683
[TBL] [Abstract][Full Text] [Related]
32. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
[TBL] [Abstract][Full Text] [Related]
33. Effect of arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Yoshikawa Y; Morikawa K; Nonaka M; Torii I
J Infect Chemother; 2004 Oct; 10(5):268-73. PubMed ID: 16163460
[TBL] [Abstract][Full Text] [Related]
34. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
[TBL] [Abstract][Full Text] [Related]
35. [Combined effects of arbekacin with biapenem against in vitro and in vivo model of a mixture of MRSA and Pseudomonas aeruginosa].
Niida M; Sakakibara S; Kawabata T; Maebashi K; Takata T; Hikida M
Jpn J Antibiot; 2004 Jun; 57(3):288-93. PubMed ID: 15376787
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of arbekacin against clinical isolates of methicillin-resistant Staphylococcus aureus in a hospital.
Kawakami Y; Furuwatari C; Akahane T; Okimura Y; Furihata K; Katsuyama T; Matsumoto H
J Antibiot (Tokyo); 1994 Apr; 47(4):507-9. PubMed ID: 8195054
[No Abstract] [Full Text] [Related]
37. [Antibacterial activities of arbekacin, a new aminoglycoside antibiotic, against methicillin-cephem-resistant Staphylococcus aureus].
Watanabe T; Goi H; Hara T; Sugano T; Tanaka Y; Kazuno Y; Matsuhashi Y; Yamamoto H; Yokota T
Jpn J Antibiot; 1987 Feb; 40(2):349-56. PubMed ID: 3648153
[TBL] [Abstract][Full Text] [Related]
38. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus.
Matsuo H; Kobayashi M; Kumagai T; Kuwabara M; Sugiyama M
FEBS Lett; 2003 Jul; 546(2-3):401-6. PubMed ID: 12832077
[TBL] [Abstract][Full Text] [Related]
40. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
